MarketCap
Facebook
X
TelegramFluidigm Corporation ROE Ratio 2011-2026 | FLDM
Annual ROE Ratio Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -38.13 | -42.18 | -81.83 | -195.68 | -142.74 | -46.4 | -35.12 | -17.14 | -18.9 | -39.49 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -17.14 | -195.68 | -65.76 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 18.56 | - | $ 196 M |  China |
 |
Agilent Technologies
A
|
22.45 | $ 113.26 | - | $ 34.4 B |  USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.63 | - | $ 2.17 M | USA |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 18.88 | - | $ 547 M | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.19 | - | $ 490 M | USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 20.49 | - | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 96.67 | - | $ 6.52 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 419.17 | - | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 041.91 | - | $ 21.5 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 3.62 | - | $ 335 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.36 | - | $ 1.07 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 18.93 | - | $ 424 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 196.91 | - | $ 19.4 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 159.12 | - | $ 7.89 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 25.5 | - | $ 24.2 B |  Niderland |
 |
Guardant Health
GH
|
419.21 | $ 98.66 | - | $ 12.4 B | USA |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 5.82 | - | $ 243 M | USA |
 |
Personalis
PSNL
|
-31.12 | $ 6.71 | - | $ 599 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 117.09 | - | $ 9.66 B |  Irlanda |
 |
Illumina
ILMN
|
-51.54 | $ 143.24 | - | $ 22.8 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.99 | - | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-121.14 | $ 2.41 | - | $ 5.54 M | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 448.21 | - | $ 169 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 254.02 | - | $ 21.1 B | USA |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.58 | - | $ 208 M | Irlanda |
 |
Celcuity
CELC
|
-176.06 | $ 134.72 | - | $ 6.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 52.95 | - | $ 3.17 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 8.43 | - | $ 1.83 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 187.94 | - | $ 20.9 B | USA |